Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Meeker County Memorial Hospital
mi
from
Lichfield, MN
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Meeker County Memorial Hospital
mi
from
Lichfield, MN
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Immanuel St. Joseph's Clinic
mi
from
Mankato, MN
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Immanuel St. Joseph's Clinic
mi
from
Mankato, MN
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
HealthEast Cancer Care at St. John's Hospital
mi
from
Maplewood, MN
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
HealthEast Cancer Care at St. John's Hospital
mi
from
Maplewood, MN
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Minnesota Oncology Hematology, PA at Maplewood Cancer Center
mi
from
Maplewood, MN
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Minnesota Oncology Hematology, PA at Maplewood Cancer Center
mi
from
Maplewood, MN
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Virginia Piper Cancer Institute at Abbott - Northwestern Hospital
mi
from
Minneapolis, MN
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Virginia Piper Cancer Institute at Abbott - Northwestern Hospital
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Hennepin County Medical Center - Minneapolis
mi
from
Minneapolis, MN
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Hennepin County Medical Center - Minneapolis
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Chippewa County - Montevideo Hospital
mi
from
Montevideo, MN
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Chippewa County - Montevideo Hospital
mi
from
Montevideo, MN
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Hubert H. Humphrey Cancer Center at North Memorial Medical Center
mi
from
Robbinsdale, MN
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Hubert H. Humphrey Cancer Center at North Memorial Medical Center
mi
from
Robbinsdale, MN
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Coborn Cancer Center
mi
from
Saint Cloud, MN
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Coborn Cancer Center
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Adult and Pediatric Urology, PLLP
mi
from
Sartell, MN
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Adult and Pediatric Urology, PLLP
mi
from
Sartell, MN
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Saint Francis Cancer Center
mi
from
Shakopee, MN
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Saint Francis Cancer Center
mi
from
Shakopee, MN
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
St. Joseph's Hospital
mi
from
St Paul, MN
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
St. Joseph's Hospital
mi
from
St Paul, MN
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
CentraCare Clinic - River Campus
mi
from
St. Cloud, MN
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
CentraCare Clinic - River Campus
mi
from
St. Cloud, MN
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Park Nicollet Health Services
mi
from
St. Louis Park, MN
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Park Nicollet Health Services
mi
from
St. Louis Park, MN
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Regions Hospital Cancer Care Center
mi
from
St. Paul, MN
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Regions Hospital Cancer Care Center
mi
from
St. Paul, MN
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
United Hospital
mi
from
St. Paul, MN
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
United Hospital
mi
from
St. Paul, MN
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Ridgeview Medical Center
mi
from
Waconia, MN
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Ridgeview Medical Center
mi
from
Waconia, MN
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Minnesota Oncology and Hematology PA-Woodbury
mi
from
Woodbury, MN
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Minnesota Oncology and Hematology PA-Woodbury
mi
from
Woodbury, MN
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Woodwinds Health Campus
mi
from
Woodbury, MN
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Woodwinds Health Campus
mi
from
Woodbury, MN
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Cancer Resource Center - Lincoln
mi
from
Lincoln, NE
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Cancer Resource Center - Lincoln
mi
from
Lincoln, NE
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Immanuel Medical Center
mi
from
Omaha, NE
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Immanuel Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Alegent Health Cancer Center at Bergan Mercy Medical Center
mi
from
Omaha, NE
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Alegent Health Cancer Center at Bergan Mercy Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Creighton University Medical Center
mi
from
Omaha, NE
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Creighton University Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Bismarck Cancer Center
mi
from
Bismarck, ND
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Bismarck Cancer Center
mi
from
Bismarck, ND
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Cancer Care Center at Medcenter One Hospital
mi
from
Bismarck, ND
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Cancer Care Center at Medcenter One Hospital
mi
from
Bismarck, ND
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Mid Dakota Clinic, P. C.
mi
from
Bismarck, ND
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Mid Dakota Clinic, P. C.
mi
from
Bismarck, ND
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
St. Alexius Medical Center
mi
from
Bismarck, ND
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
St. Alexius Medical Center
mi
from
Bismarck, ND
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
CCOP - MeritCare Hospital
mi
from
Fargo, ND
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
CCOP - MeritCare Hospital
mi
from
Fargo, ND
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
MeritCare Medical Group
mi
from
Fargo, ND
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
MeritCare Medical Group
mi
from
Fargo, ND
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Wood County Oncology Center
mi
from
Bowling Green, OH
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Wood County Oncology Center
mi
from
Bowling Green, OH
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Grandview Hospital
mi
from
Dayton, OH
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Grandview Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Good Samaritan Hospital
mi
from
Dayton, OH
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Good Samaritan Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
David L. Rike Cancer Center at Miami Valley Hospital
mi
from
Dayton, OH
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
David L. Rike Cancer Center at Miami Valley Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Samaritan North Cancer Care Center
mi
from
Dayton, OH
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Samaritan North Cancer Care Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Veterans Affairs Medical Center - Dayton
mi
from
Dayton, OH
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Veterans Affairs Medical Center - Dayton
mi
from
Dayton, OH
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
CCOP - Dayton
mi
from
Dayton, OH
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
CCOP - Dayton
mi
from
Dayton, OH
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Blanchard Valley Medical Associates
mi
from
Findlay, OH
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Blanchard Valley Medical Associates
mi
from
Findlay, OH
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Fremont Memorial Hospital
mi
from
Fremont, OH
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Fremont Memorial Hospital
mi
from
Fremont, OH
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Kenton Oncology, Incorporated
mi
from
Kenton, OH
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Kenton Oncology, Incorporated
mi
from
Kenton, OH
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Charles F. Kettering Memorial Hospital
mi
from
Kettering, OH
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Charles F. Kettering Memorial Hospital
mi
from
Kettering, OH
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Lima Memorial Hospital
mi
from
Lima, OH
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Lima Memorial Hospital
mi
from
Lima, OH
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Northwest Ohio Oncology Center
mi
from
Maumee, OH
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Northwest Ohio Oncology Center
mi
from
Maumee, OH
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
St. Luke's Hospital
mi
from
Maumee, OH
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
St. Luke's Hospital
mi
from
Maumee, OH
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Middletown Regional Hospital
mi
from
Middletown, OH
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Middletown Regional Hospital
mi
from
Middletown, OH
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
St. Charles Mercy Hospital
mi
from
Oregon, OH
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
St. Charles Mercy Hospital
mi
from
Oregon, OH
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Toledo Clinic - Oregon
mi
from
Oregon, OH
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Toledo Clinic - Oregon
mi
from
Oregon, OH
Click here to add this to my saved trials
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Firelands Regional Medical Center
mi
from
Sandusky, OH
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Firelands Regional Medical Center
mi
from
Sandusky, OH
Click here to add this to my saved trials